Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
disease | 1.000 | limited | 0.896 | 0 | 63 | 1996 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.947 | 0 | 1 | 2005 | 2020 | ||||||||
|
RAD54 like | 0.633 | 0.423 | 2.4E-15 |
|
disease | 0.620 | None | 0.500 | 0 | 1 | 2017 | 2017 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.600 | None | 0.950 | 0 | 0 | 1999 | 2020 | ||||||||
|
prohibitin | 0.511 | 0.846 | 0.76 |
|
disease | 0.600 | None | 0.944 | 0 | 2 | 1994 | 2018 | ||||||||
|
signal transducer and activator of transcription 1 | 0.399 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
protein phosphatase, Mg2+/Mn2+ dependent 1D | 0.513 | 0.808 | 2.2E-11 |
|
disease | 0.600 | None | 0.964 | 0 | 0 | 2002 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 1 | 1995 | 2019 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.500 | None | 0.909 | 0 | 2 | 2000 | 2019 | ||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.500 | None | 0 | 0 | |||||||||||
|
Obg like ATPase 1 | 0.780 | 0.269 | 5.8E-02 |
|
disease | 0.420 | None | 0.667 | 0 | 1 | 2009 | 2014 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
disease | 0.420 | None | 1.000 | 0 | 1 | 2010 | 2014 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
sorbin and SH3 domain containing 1 | 0.554 | 0.769 | 1.5E-12 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2009 | 2020 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
programmed cell death 4 | 0.494 | 0.769 | 3.4E-07 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
GLI family zinc finger 1 | 0.431 | 0.846 | 7.7E-14 |
|
disease | 0.400 | None | 0.972 | 0 | 0 | 2006 | 2019 | ||||||||
|
gelsolin | 0.475 | 0.885 | 3.9E-11 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 1996 | 2018 | ||||||||
|
MRE11 homolog, double strand break repair nuclease | 0.527 | 0.808 | 1.3E-12 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2008 | 2019 | ||||||||
|
NHS actin remodeling regulator | 0.466 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.990 | 0 | 0 | 2001 | 2020 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 1 | 0.453 | 0.846 | 0.14 |
|
disease | 0.400 | None | 1.000 | 0 | 1 | 2016 | 2020 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 2 | 0.456 | 0.846 | 3.5E-08 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2016 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2007 | 2020 | ||||||||
|
X-box binding protein 1 | 0.477 | 0.846 | 3.2E-02 |
|
disease | 0.400 | None | 1.000 | 0 | 1 | 2003 | 2019 |